Profarma Distribuidora de Produtos Farmacêuticos S.A., headquartered in Brazil, is a leading player in the pharmaceutical distribution industry. Established in 1992, the company has grown to serve major operational regions across the country, providing essential healthcare products to pharmacies, hospitals, and clinics. Profarma's core offerings include a wide range of pharmaceutical products, medical supplies, and health-related services, distinguished by their commitment to quality and efficiency. The company has achieved significant milestones, positioning itself as a trusted partner in the healthcare supply chain. With a strong market presence, Profarma continues to innovate and adapt, ensuring that healthcare providers have access to the products they need to deliver optimal patient care.
How does Profarma Distribuidora de Produtos Farmacêuticos S.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Profarma Distribuidora de Produtos Farmacêuticos S.A.'s score of 33 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Profarma Distribuidora de Produtos Farmacêuticos S.A. reported total carbon emissions of approximately 9,000,160 kg CO2e. This figure includes 3,292,150 kg CO2e from Scope 1 emissions, 846,880 kg CO2e from Scope 2 emissions, and 5,294,130 kg CO2e from Scope 3 emissions. The emissions data for 2022 mirrored these figures, indicating a consistent emission profile over the two years. Currently, Profarma has not established any specific reduction targets or climate pledges, nor does it inherit emissions data from a parent company. The absence of reduction initiatives suggests that the company may be in the early stages of developing a comprehensive climate strategy. As the pharmaceutical distribution sector increasingly prioritises sustainability, Profarma's future commitments will be crucial in aligning with industry standards and expectations.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 3,292,150 | 0,000,000 |
| Scope 2 | 846,880 | 000,000 |
| Scope 3 | 5,294,130 | 0,000,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Profarma Distribuidora de Produtos Farmacêuticos S.A. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

